Inovio Pharma (NASDAQ: INO) reported Q3 EPS of ($0.09), $0.04 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $390 thousand versus the consensus estimate of $116.67 thousand.

For earnings history and earnings-related data on Inovio Pharma (INO) click here.